Unipotent stem cells are the least-known type of stem cell. They are stem cells that are differentiated and limited to developing into only one type of cell or cell line. Unlike pluripotent stem cells, which could become any cell type, and multipotent stem cells, which are able to become a few different cell types, unipotent stem cells are restricted to developing into a single type of cell. Unipotent stem cells were first isolated from human umbilical cord blood in 1998, and since then have been found to exist in various tissues including bone marrow, lung, skin, and muscle. Unipotent stem cells are found most commonly in adult tissues. They possess the capacity to renew themselves and differentiate into the cell type they are predestined to become, and their differentiation is considered to be a phenotype selection from other progenitor cells in the tissue. The major benefit of using unipotent stem cells is that they can be directed into the cell type of the researcher’s choice, providing researchers with a relatively unlimited source of the cell type they need. Unipotent stem cells are the most difficult of the three major stem cell types to manipulate as their differentiation is limited, and so fewer research tools are available for this type of stem cell biology than for pluripotent and multipotent stem cells. Additionally, the potential medical applications for unipotent stem cell-based therapies are significantly narrower than those for multipotent and pluripotent stem cell research. Research into unipotent stem cells has generated great promise due to its potential use in tissue engineering and for healing diseases, such as Alzheimer’s, Parkinson’s, cancer, and diabetes. Early studies have suggested that unipotent stem cells could be used to replace cells damaged due to disease, aging, or injury, meaning unipotent stem cells could offer potential therapeutic treatments for a range of medical conditions.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States